"I'm so pleased to receive this award," Gulati said. "A lot of credit goes to my students who have contributed to my success and are now holding senior positions and making significant contributions in biotechnology."
Throughout his 35-year career, Gulati has made a lasting impact on student pharmacists, graduate students, postdoctoral researchers, medical fellows and colleagues. As professor and associate dean of research at
"Dr. Gulati sets high standards for his students, and then coaches and guides them to achieving those standards," said
Gulati is a nationally and internationally recognized expert in endothelin, which is a protein that constricts blood vessels and raises blood pressure. He has founded three pharmaceutical/biotechnology companies and as a result, some of his discoveries related to endothelin are undergoing clinical trials to translate into novel therapies in the areas of cancer treatment, neuroprotection, pain management and resuscitation from hemorrhagic shock. In 2007, Gulati received the
The author of more than 285 peer-reviewed publications and recipient of 32 patents and inventions, Gulati says he is humbled to receive the Dawson award. He added, "It is a marvelous feeling to be listed among all those accomplished scientists and educators" who have previously received the award.
"From its inception the Dawson Award has recognized outstanding scientists who have worked at the frontier of so many important research areas. Dr. Gulati has certainly done this while engaging learners to fully integrate science into clinical education and practice." The 2014 AACP Annual Meeting will be held
Keywords for this news article include: Biotechnology, Clinical Trials and Studies,
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC
Most Popular Stories
- Criminal Investigation Opened Into James Foley's Death
- The Hip New Career? Farming
- McDonald's Names Another U.S. President
- Student Startup Develops Date-rape Detector
- Sahara Casino Rises Anew as SLS Las Vegas
- Chinese Coal Gas Boom Poses Climate Risks
- Job Market Shifts Complicate Yellen's Rate Decision
- Is Diversity in the Eye of the Beholder?
- U.S. Supporters of Islamic State Get Close Scrutiny
- Dems Losing Fear of Obamacare